(Q42991623)

12 November 2017

Regression of hepatic fibrosis in hepatitis C with long-term interferon treatment (English)

1 reference

12 November 2017

1 reference

Dufour JF

1

1 reference

12 November 2017

DeLellis R

series ordinal

2

1 reference

12 November 2017

Kaplan MM

series ordinal

3

1 reference

12 November 2017

1 December 1998

1 reference

Digestive Diseases and Sciences

12 November 2017

1 reference

12 November 2017

43

1 reference

12 November 2017

12

1 reference

12 November 2017

2573-2576

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1026601904609

12 November 2017

0 references

cites work

Improvement of liver fibrosis in chronic hepatitis C patients treated with natural interferon alpha

1 reference

12 December 2020

Clinical outcomes after transfusion-associated hepatitis C.

1 reference

12 December 2020

A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group

1 reference

12 December 2020

Randomised trial of lymphoblastoid alpha-interferon in chronic hepatitis C. Effects on inflammation, fibrogenesis and viremia

1 reference

12 December 2020

Interferon alfa and gamma inhibit proliferation and collagen synthesis of human Ito cells in culture

1 reference

12 December 2020

Reversal of “Cirrhosis” in Idiopathic Haemochromatosis Following Long-term Intensive Venesection Therapy

1 reference

12 December 2020

Penicillamine-induced normalization of clinical signs, and liver morphology and histochemistry in a case of Wilson's disease

1 reference

12 December 2020

A histopathological study of the effects of 6-month versus 12-month interferon α-2b therapy in chronic hepatitis C

1 reference

12 December 2020

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

12 December 2020

Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment

1 reference

12 December 2020

Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy

1 reference

12 December 2020

Interferon-alpha 2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: a quantitative histological evaluation

1 reference

12 December 2020

Sampling Variability on Percutaneous Liver Biopsy

1 reference

12 December 2020

Reversibility of hepatic fibrosis in autoimmune hepatitis

1 reference

12 December 2020

Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1026601904609

1 reference

Dimensions Publication ID

12 November 2017

0 references

1 reference